all news

Our partners are building great companies. We love to share their stories.

Fri, 21 Jun 2024 Neumora Therapeutics, Inc.

Neumora Therapeutics Announces Initiation of Phase 1b Study of NMRA-511 for Treatment of Alzheimer’s Disease Agitation | Neumora Therapeutic

Thu, 20 Jun 2024 businesswire.com

Tectonic Therapeutic Announces Closing of Merger with AVROBIO as well as Concurrent Private Placement of $130.7 Million

Wed, 19 Jun 2024 PRWeb

Panalgo and OM1 Expand Partnership to Offer OM1's PremiOM Datasets in Panalgo's IHD Analytics Platform

Mon, 17 Jun 2024 Associated Press

Nomad Health Secures $22 Million; Justin Lambert Appointed CEO

Fri, 14 Jun 2024 Associated Press

Seraxis Wins Maryland Stem Cell Research Fund Grant to Accelerate Development of Allogenetically Compatible Pancreatic Islet Replacement Therapy for Functional Cure of T1D

Thu, 13 Jun 2024 businesswire.com

OM1, a Pioneer in Patient Registries, Launches Its Registries Center of Excellence

Wed, 12 Jun 2024 KSQ Therapeutics

KSQ Therapeutics Announces First Patient Dosed in Clinical Development Program for KSQ-001EX, a CRISPR/Cas9 Engineered Tumor Infiltrating Ly

Wed, 12 Jun 2024 PR Newswire

Triveni Bio Appoints Bhaskar Srivastava, M.D., Ph.D., as Chief Medical Officer, Announces Key Program Updates

Tue, 11 Jun 2024 GlobeNewswire

Faraday Pharmaceuticals Announces Completion of Enrollment in Pivotal Phase 3 Iocyte AMI-3 Trial of FDY-5301

Tue, 11 Jun 2024 PR Newswire

QurAlis Expands Leadership Team With Doug Williamson, M.D., as Chief Medical Officer and Jason Brown, MBA, as Chief Financial Officer and Appoints Shafique Virani, M.D., to Board of Directors

Tue, 4 Jun 2024 Massachusetts Biotechnology Council

Member Spotlight: Q&A with KSQ Therapeutics

Tue, 4 Jun 2024 Associated Press

Cohere Health, Medical Mutual, and Rhyme Partner on Utilization Management Transformation

Tue, 4 Jun 2024 Food Business News

ByHeart expanding reach of infant formula products

Wed, 29 May 2024 PR Newswire

Quantcast Launches Innovative Advertising Platform, Inviting Agencies and Advertisers of All Sizes to the Open Web

Wed, 22 May 2024 Scholar Rock Holding Corp

Scholar Rock Announces Initiation of Phase 2 EMBRAZE Trial of Apitegromab in Obesity and New Preclinical Data Supporting SRK-439 in Obesity

Wed, 22 May 2024 GlobeNewswire

Noema Pharma Announces First Patient Dosed in Phase 2a Study of NOE-115, a First-In-Class Investigational Therapy for the Treatment of Vasomotor Symptoms and Additional Symptoms Associated with Menopause

Thu, 16 May 2024 PR Newswire

Proof and Socure partner to combat fraud and forgery in the $200 trillion exchanged through contracts, authorizations, and forms

Wed, 15 May 2024 PR Newswire

Pulmatrix Announces Peer-Reviewed Publication of Clinical Results for its Orally Inhaled DHE for Acute Migraine (PUR3100)

Tue, 14 May 2024 aTyr Pharma, Inc.

aTyr Pharma Announces Second Positive DSMB Review for Efzofitimod in Phase 3 EFZO-FIT™ Study in Pulmonary Sarcoidosis

Tue, 14 May 2024 Associated Press

Maryland Stem Cell Research Commission Announces $15.4 Million in Awards to Accelerate Cures

Tue, 14 May 2024 GlobeNewswire

Neumora Therapeutics Announces Initiation of Phase 2 Study of Navacaprant in Bipolar Depression

Tue, 14 May 2024 Drug Discovery Online

Gene Therapy: How Should We Approach Benefit And Risk?

Mon, 6 May 2024 Associated Press

Quest Diagnostics To Acquire PathAI Diagnostics To Accelerate AI and Digital Pathology Adoption in Cancer Diagnosis; Forms Licensing Agreements With PathAI

Mon, 6 May 2024 Business Wire

OM1 Launches Three New Products Powered by Patented AI Platform to Expedite Delivery of Personalized Medicine

Mon, 6 May 2024 Business Wire

Egnyte Launches Content Security Ecosystem to Help Businesses Gain Better Control Over Their Data and Enhance Their Security Posture

Thu, 2 May 2024 Associated Press

Livara Health Raises $15 Million to Expand Value-Based Musculoskeletal Care Delivery Model

Thu, 2 May 2024 Associated Press

Delphia Therapeutics Launches to Pioneer a New Field of Cancer Medicines: Activation Lethality

Wed, 10 Apr 2024 GlobeNewswire

FloQast Secures $100 Million in Series E Funding

Tue, 9 Apr 2024 Unknown

OM1 and Medtronic Partner on Propel Study to Assess Long-term Outcomes for Patients with Chronic Rhinosinusitis